From: Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
afatinib
bosutinib
crizotinib
gefitinib
ponatinib
regorafenib
sorafenib
sunitinib
tamoxifen
trametinib
vandetanib